Molecular Partners (ADR) (MOLN)
Develops DARPin cancer therapies, including Radio-DARPins and immune-cell engagers.
$4.24
Pre-market+0.03 (+0.65%)
At close$4.21(−1.75%)
Something off on this page? Send us feedback.
Next report
Oct 29, 2026
in 56 days
EPS estimate
−$0.46
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Oct '25Mar '26May '26Aug '26Oct '26
Reported−$0.34−$0.50−$0.67−$0.41−$0.41−$0.45−$0.44Pending
Estimate−$0.44−$0.42−$0.53−$0.46−$0.40−$0.38−$0.45−$0.46
Surprise+22.7%−18.6%−26.4%+10.9%−2.5%−18.4%+2.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Oct '25Mar '26May '26Aug '26Oct '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | −$0.46 | — | — |
| Aug 2026 | −$0.45 | −$0.44 | +2.2% |
| May 2026 | −$0.38 | −$0.45 | −18.4% |
| Mar 2026 | −$0.40 | −$0.41 | −2.5% |
| Oct 2025 | −$0.46 | −$0.41 | +10.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Oct 2021 | |||
| Aug 2021 | |||
| Jun 2021 | |||
| Feb 2021 | |||
| Dec 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | −$0.46 | — | — | — | — | — | — |
| Aug 25, 2026 | −$0.45 | −$0.44 | +2.2% | — | — | — | −0.5% |
| May 12, 2026 | −$0.38 | −$0.45 | −18.4% | — | — | — | −1.0% |
| Mar 12, 2026 | −$0.40 | −$0.41 | −2.5% | — | — | — | −10.4% |
| Oct 30, 2025 | −$0.46 | −$0.41 | +10.9% | — | — | — | −3.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 25, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 6, 2025 | |||||||
| Oct 31, 2024 | |||||||
| Aug 26, 2024 | |||||||
| May 16, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Oct 26, 2023 | |||||||
| Aug 23, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Oct 27, 2022 | |||||||
| Aug 25, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 15, 2022 | |||||||
| Oct 28, 2021 | |||||||
| Aug 26, 2021 | |||||||
| Jun 16, 2021 | |||||||
| Feb 26, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 | |||||||